Cargando…
Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients—Focus on Clinical and Histopathological Variation
Background: The most common autoimmune blistering disease, bullous pemphigoid (BP), shows an increased prevalence in psoriatic patients and oncologic patients undergoing immune-checkpoint blockade (ICB). Even though the same autoantigens (BP180/BP230) are detectable, it remains obscure whether clini...
Autores principales: | Niebel, Dennis, Wilsmann-Theis, Dagmar, Bieber, Thomas, Berneburg, Mark, Wenzel, Joerg, Braegelmann, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947168/ https://www.ncbi.nlm.nih.gov/pubmed/35323203 http://dx.doi.org/10.3390/dermatopathology9010010 |
Ejemplares similares
-
Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines
por: Niebel, Dennis, et al.
Publicado: (2021) -
Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective
por: Niebel, Dennis, et al.
Publicado: (2021) -
Bullous Pemphigoid Associated with Adalimumab Therapy in a Patient with Ulcerative Colitis
por: Hoffmann, Sebastian, et al.
Publicado: (2018) -
Specialized dermatological-rheumatological patient management improves diagnostic outcome and patient journey in psoriasis and psoriatic arthritis: a four-year analysis
por: Ziob, Jana, et al.
Publicado: (2021) -
Immunostimulatory Endogenous Nucleic Acids Perpetuate Interface Dermatitis—Translation of Pathogenic Fundamentals Into an In Vitro Model
por: Braegelmann, Christine, et al.
Publicado: (2021)